Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Colorectal Cancer Reports
Published in: Current Colorectal Cancer Reports 1/2017

01-02-2017 | Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Local Excision Versus Total Mesorectal Excision for Clinical Stage I (cT1–cT2) Rectal Cancer

Authors: Woramin Riansuwan, Varut Lohsiriwat

Published in: Current Colorectal Cancer Reports | Issue 1/2017

Login to get access

Abstract

Early rectal cancer (cT1 and cT2) has been increasingly detected due to the wide application of colorectal cancer screening program. Total mesorectal excision (TME) is a gold standard for the treatment of this early stage disease. However, postoperative complications, unfavorable functional outcomes, and risk of permanent stoma following TME are not uncommon. In contrast, local excision (LE) is less invasive and more tolerable to frail patients and those with severe co-morbidities. Simultaneously, both functional and sexual outcomes following LE were not disturbed and the patient could avoid abdominoperineal resection. The drawback of LE is leaving perirectal lymph node yielding unknown actual pathological nodal staging—which partly leads to more recurrence comparing to TME. This article aimed to review the current evidence of TME and LE in early rectal cancer, to critically review the role and consequence of chemoradiation in LE, and to update ongoing trials on this subject.
Literature
1.
Stamos MJ, Murrell Z. Management of early rectal T1 and T2 cancers. Clin Cancer Res. 2007; 13: 6885s-9s.
2.
Endreseth BH, Myrvold HE, Romundstad P, et al. Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum. 2005;48:1380–8.CrossRefPubMed
3.
Madbouly KM, Remzi FH, Erkek BA, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Dis Colon Rectum. 2005;48:711–9.CrossRefPubMed
4.
Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242:472–7.PubMedPubMedCentral
5.
Blumberg D, Paty PB, Guillem JG, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum. 1999;42:881–5.CrossRefPubMed
6.
7.
Mason AY. Transsphincteric approach to rectal lesions. Surg Annu. 1977;9:171–94.PubMed
8.
Kraske P, Perry EG, Hinrichs B. A new translation of professor Dr P. Kraske’s Zur Exstirpation Hochsitzender Mastdarmkrebse. 1885. Aust N Z J Surg. 1989;59:421–4.PubMed
9.
Engstrom PF, Arnoletti JP, Benson 3rd AB, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009;7:838–81.PubMed
10.
Buess G, Theiss R, Hutterer F, et al. Transanal endoscopic surgery of the rectum—testing a new method in animal experiments. Leber Magen Darm. 1983;13:73–7.PubMed
11.
Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24:2200–5.CrossRefPubMed
12.
McLemore E, Coker A, Jacobsen G, et al. eTAMIS: endoscopic visualization for transanal minimally invasive surgery. Surg Endosc. 2013;27:1842–5.CrossRefPubMed
13.
Gotoda T, Kondo H, Ono H, et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc. 1999;50:560–3.CrossRefPubMed
14.
Kudo S, Kashida H, Nakajima T, Tamura S, Nakajo K. Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg. 1997;21:694–701.CrossRefPubMed
15.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003; 58 (6, Suppl): S3-S43.
16.
Nascimbeni R, Burgart LJ, Nivatvong S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45:200–6.CrossRefPubMed
17.
Wirsing K, Lorenzo-Rivero S, Luchtefeld M, et al. Local excision of stratified T1 rectal cancer. Am J Surg. 2006;191:410–2.CrossRefPubMed
18.
Lohsiriwat V, Anubhonganant W, Prapasrivorakul S, et al. Outcomes of local excision for early rectal cancer: a 6-year experience from the largest university hospital in Thailand. Asian Pac J Cancer Prev. 2013;14:5141–4.CrossRefPubMed
19.
Willett CG, Compton CC, Shellito PC, Efird JT. Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer. 1994;73:2716–20.CrossRefPubMed
20.
Garcia-Aguilar J, Mellgren A, Sirivongs P, et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg. 2000;231:345–51.CrossRefPubMedPubMedCentral
21.
Mellgren A, Sirivongs P, Rothenberger DA, et al. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000;43:1064–71.CrossRefPubMed
22.
Nascimbeni R, Nivatvongs S, Larson DR, et al. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum. 2004;47:1773–9.CrossRefPubMed
23.
Nash GM, Weiser MR, Guillem JG, et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum. 2009;52:577–82.CrossRefPubMed
24.
Kikuchi R, Takano M, Takagi K, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38:1286–95.CrossRefPubMed
25.
Kitajima K, Fujimori T, Fujii S, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39:534–43.CrossRefPubMed
26.
Gopaul D, Belliveau P, Vuong T, et al. Outcome of local excision of rectal carcinoma. Dis Colon Rectum. 2004;47:1780–8.CrossRefPubMed
27.
You YN, Baxter NN, Stewart A, et al. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245:726–33.CrossRefPubMedPubMedCentral
28.
Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An Epidemiologic Study Ann Surg. 2007;246:215–21.PubMed
29.
Christoforidis D, Cho HM, Dixon MR, et al. Transanal endoscopic microsurgery versus conventional transanal excision for patients with early rectal cancer. Ann Surg. 2009;249:776–82.CrossRefPubMed
30.
Doornebosch PG, Ferenschild FT, de Wilt JH, et al. Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum. 2010;53:1234–9.CrossRefPubMed
31.
Winde G, Nottberg H, Keller R, Schmid KW, Bünte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum. 1996;39:969–76.CrossRefPubMed
32.
De Graaf EJ, Doornebosch PG, Tollenaar RA, et al. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol. 2009;35:1280–5.CrossRefPubMed
33.
Friel CM, Cromwell JW, Marra C, et al. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum. 2002;45:875–9.CrossRefPubMed
34.
Weiser MR, Landmann RG, Wong WD, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum. 2005;48:1169–75.CrossRefPubMed
35.
Baron PL, Enker WE, Zakowski MF, et al. Immediate vs. salvage resection after local treatment for early rectal cancer. Dis Colon Rectum. 1995;38:177–81.CrossRefPubMed
36.
Hahnloser D, Wolff BG, Larson DW, et al. Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum. 2005;48:429–37.CrossRefPubMed
37.
de Anda E, Lee SH, Finne CO, et al. Endorectal ultrasound in the follow-up of rectal cancer patients treated by local excision or radical surgery. Dis Colon Rectum. 2004;47:818–24.CrossRefPubMed
38.
Chakravarti A, Compton CC, Shellito PC, et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg. 1999;230:49–54.CrossRefPubMedPubMedCentral
39.
Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys. 2000;46:313–22.CrossRefPubMed
40.
Greenberg JA, Shibata D, Herndon JE, et al. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum. 2008;51:1185–91.CrossRefPubMed
41.
Borstlap WA, Tanis PJ, Koedam TW, et al. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer. 2016;16:513.CrossRefPubMedPubMedCentral
42.
Bonnen M, Crane C, Vauthey JN, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004;60:1098–105.CrossRefPubMed
43.
Lezoche E, Guerrieri M, Paganini AM, et al. Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg. 2005;92:1546–52.CrossRefPubMed
44.
• Lezoche G, Baldarelli M, Guerrieri M, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc. 2008;22:352–8. A prospective RCT evaluating long-term outcomes between TEM vs. laparoscopic TME in rectal cancer patients after receiving chemoradiation.CrossRefPubMed
45.
•• Garcia-Aguilar J, Renfro LA, Chow OS, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16:1537–46. A phase II prospective trial evaluating the outcomes after LE in T2N0 rectal cancer patients.CrossRefPubMedPubMedCentral
46.
• Verseveld M, de Graaf EJ, Verhoef C, et al. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). Br J Surg. 2015;102:853–60. A European multicenter prospective study determining outcomes of TEM after long course chemoradiation.CrossRefPubMed
47.
48.
Metadata
Title
Local Excision Versus Total Mesorectal Excision for Clinical Stage I (cT1–cT2) Rectal Cancer
Authors
Woramin Riansuwan
Varut Lohsiriwat
Publication date
01-02-2017
Publisher
Springer US
Published in
Current Colorectal Cancer Reports / Issue 1/2017
Print ISSN: 1556-3790
Electronic ISSN: 1556-3804
DOI
https://doi.org/10.1007/s11888-017-0350-0

Other articles of this Issue 1/2017

Current Colorectal Cancer Reports 1/2017 Go to the issue

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Current Status of Laparoscopic Surgery in Colorectal Cancer

Personalized Medicine in Colorectal Cancer (D Cunningham and EC Smyth, Section Editors)

Molecular Stratification of Colorectal Cancer: Moving from the Laboratory to Clinical Practice

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Current Concepts on the Distal Margin of Resection of Rectal Cancer Tumors after Neoadjuvant Chemoradiation

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Lymphadenectomy in Colorectal Cancer: Therapeutic Role and How Many Nodes Are Needed for Appropriate Staging?

Radiation Therapy and Radiation Therapy Innovations in Colorectal Cancer (JY Wo, Section Editor)

The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes in Rectal Cancer

Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Robotic Surgery for Colon and Rectal Cancer: Current Status, Recent Advances, and Future Directions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits